| Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC | |
| Li, Butuo; Li, Cheng; Guo, Meiying; Shang, Shuheng; Li, Xiaogang; Xie, Peng; Sun, Xindong; Yu, Jinming; Wang, Linlin | |
| 刊名 | ONCOTARGETS AND THERAPY
 |
| 2018 | |
| 卷号 | 11页码:6287-6294 |
| 关键词 | lactate dehydrogenase bevacizumab non-small-cell lung cancer mixed-effect model predictive factor |
| DOI | 10.2147/OTT.S171566 |
| URL标识 | 查看原文 |
| 公开日期 | [db:dc_date_available] |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4578439 |
| 专题 | 山东大学 |
| 作者单位 | 1.Tianjin Med Univ, Dept Radiat Oncol, Tianjin, Peoples R China. 2.Tianjin Med Univ, Key Lab Canc Pre |
| 推荐引用方式 GB/T 7714 | Li, Butuo,Li, Cheng,Guo, Meiying,et al. Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC[J]. ONCOTARGETS AND THERAPY,2018,11:6287-6294. |
| APA | Li, Butuo.,Li, Cheng.,Guo, Meiying.,Shang, Shuheng.,Li, Xiaogang.,...&Wang, Linlin.(2018).Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC.ONCOTARGETS AND THERAPY,11,6287-6294. |
| MLA | Li, Butuo,et al."Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC".ONCOTARGETS AND THERAPY 11(2018):6287-6294. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论